Outcomes and complications of percutaneous nephrolithotomy as primary versus secondary procedure for kidney stones: a prospective cohort study.

IF 1.7 Q2 MEDICINE, GENERAL & INTERNAL Annals of Medicine and Surgery Pub Date : 2024-08-30 eCollection Date: 2024-10-01 DOI:10.1097/MS9.0000000000002502
Aymen Sakly, Syrine Khaldi, Anouar Touati, Elyes Dimassi, Walid Zakhama, Yassine Binous
{"title":"Outcomes and complications of percutaneous nephrolithotomy as primary versus secondary procedure for kidney stones: a prospective cohort study.","authors":"Aymen Sakly, Syrine Khaldi, Anouar Touati, Elyes Dimassi, Walid Zakhama, Yassine Binous","doi":"10.1097/MS9.0000000000002502","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Currently, percutaneous nephrolithotomy (PCNL) is the gold standard of treatment for large renal stones. The high prevalence of urolithiasis is associated with a high recurrence rate increasing the risk of re-intervention. This study aimed to compare the effectiveness and complications of PCNL among patients with previous therapeutic interventions for renal stones.</p><p><strong>Methods: </strong>Between August 2018 and September 2023, 245 patients were prospectively enrolled in this study and who underwent PCNL for renal stones at our institution. We compared patients who had no previous renal surgery (group 1: <i>n</i>=171) with those who had a history of open renal surgery (group 2: <i>n</i>=45) or previous PCNL on the ipsilateral kidney (group 3: <i>n</i>=31). All patients underwent surgery in the Galdakao-modified Valdivia position. Data on stone characteristics and perioperative and postoperative parameters were collected. Technical features, success rates and morbidity were analyzed and compared between the groups.</p><p><strong>Results: </strong>The fluoroscopy time was significantly longer in the group of patients with previous open surgery than in groups 1 and 3 (161.47±52.44, 223.05±33.29, 172.27±30.51 sec, <i>P</i><0.001). Similarly, the operative time was longer in group 2 (138.20±38.86 min, <i>P</i><0.001). The immediate stone-free rates in groups 1, 2, and 3 were 74.8%, 72.1%, and 77.4%, respectively (<i>P</i>=0.945). At 1-month, these rates increased to 98.8%, 96.2% and 96.8%, respectively (<i>P</i>=0.857). No difference was detected between the groups in terms of complication rate. The average Hb variation was 1.08±0.82, 1.34±1.01 and 0.94±0.69 g/dl for groups 1, 2 and 3, respectively(<i>P</i>=0.082). Hospital stay was longer in group 2 than in groups 1 and 3 (2.17±1.03, 2.53±1.22, 1.88±1.00 days, <i>P</i>=0.07), respectively.</p><p><strong>Conclusion: </strong>PCNL in patients with a history of renal surgery was associated with longer fluoroscopy and operative time. However, the success and morbidity rates as a secondary procedure were similar to those of PCNL in patients with no previous intervention.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":null,"pages":null},"PeriodicalIF":1.7000,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444619/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Medicine and Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/MS9.0000000000002502","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Currently, percutaneous nephrolithotomy (PCNL) is the gold standard of treatment for large renal stones. The high prevalence of urolithiasis is associated with a high recurrence rate increasing the risk of re-intervention. This study aimed to compare the effectiveness and complications of PCNL among patients with previous therapeutic interventions for renal stones.

Methods: Between August 2018 and September 2023, 245 patients were prospectively enrolled in this study and who underwent PCNL for renal stones at our institution. We compared patients who had no previous renal surgery (group 1: n=171) with those who had a history of open renal surgery (group 2: n=45) or previous PCNL on the ipsilateral kidney (group 3: n=31). All patients underwent surgery in the Galdakao-modified Valdivia position. Data on stone characteristics and perioperative and postoperative parameters were collected. Technical features, success rates and morbidity were analyzed and compared between the groups.

Results: The fluoroscopy time was significantly longer in the group of patients with previous open surgery than in groups 1 and 3 (161.47±52.44, 223.05±33.29, 172.27±30.51 sec, P<0.001). Similarly, the operative time was longer in group 2 (138.20±38.86 min, P<0.001). The immediate stone-free rates in groups 1, 2, and 3 were 74.8%, 72.1%, and 77.4%, respectively (P=0.945). At 1-month, these rates increased to 98.8%, 96.2% and 96.8%, respectively (P=0.857). No difference was detected between the groups in terms of complication rate. The average Hb variation was 1.08±0.82, 1.34±1.01 and 0.94±0.69 g/dl for groups 1, 2 and 3, respectively(P=0.082). Hospital stay was longer in group 2 than in groups 1 and 3 (2.17±1.03, 2.53±1.22, 1.88±1.00 days, P=0.07), respectively.

Conclusion: PCNL in patients with a history of renal surgery was associated with longer fluoroscopy and operative time. However, the success and morbidity rates as a secondary procedure were similar to those of PCNL in patients with no previous intervention.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
经皮肾镜取石术作为治疗肾结石的主要手术与次要手术的疗效和并发症:一项前瞻性队列研究。
导言:目前,经皮肾镜取石术(PCNL)是治疗大块肾结石的金标准。尿路结石的高发病率与高复发率有关,增加了再次介入治疗的风险。本研究旨在比较PCNL在既往接受过肾结石治疗干预的患者中的有效性和并发症:2018年8月至2023年9月期间,245名患者被前瞻性纳入本研究,并在我院接受了肾结石PCNL治疗。我们将既往未接受过肾脏手术的患者(第1组:n=171)与既往接受过开放性肾脏手术的患者(第2组:n=45)或既往接受过同侧肾脏PCNL的患者(第3组:n=31)进行了比较。所有患者均采用 Galdakao 改良 Valdivia 体位进行手术。收集了结石特征、围术期和术后参数的数据。对各组的技术特点、成功率和发病率进行了分析和比较:结果:曾接受过开放手术的患者组的透视时间明显长于第 1 组和第 3 组(161.47±52.44 秒、223.05±33.29 秒、172.27±30.51 秒,PPP=0.945)。1 个月后,这些比率分别增至 98.8%、96.2% 和 96.8%(P=0.857)。两组在并发症发生率方面未发现差异。第 1、2 和 3 组的平均血红蛋白变化分别为 1.08±0.82、1.34±1.01 和 0.94±0.69 g/dl(P=0.082)。第 2 组的住院时间比第 1 组和第 3 组长(分别为 2.17±1.03、2.53±1.22、1.88±1.00 天,P=0.07):有肾脏手术史的患者 PCNL 需要更长的透视和手术时间。不过,作为二次手术,其成功率和发病率与未接受过干预的 PCNL 患者相似。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Annals of Medicine and Surgery
Annals of Medicine and Surgery MEDICINE, GENERAL & INTERNAL-
自引率
5.90%
发文量
1665
期刊最新文献
Coexistence of Cecal duplication cyst and Meckel's diverticulum presenting as intestinal obstruction: a rare case report: Retraction. Bladder transitional cell carcinoma anatomic primary site as a predictor of survival and mortality: a population-based retrospective cohort study. Male breast cancer: a 32-year retrospective analysis in radiation therapy referral center in northern Iran. Bilateral visual loss as the initial presentation of chronic myeloid leukemia: a case report. Unveiling post-COVID-19 Rasmussen's encephalitis: a case report of rare neurological complication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1